American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

American Well CorporationNYSE: AMWL

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables grows, but more slowly than its trailing trend

Q1 FY2026 accounts receivables of $9.6M (cash outflow) rose 32.0% year over year, behind the +307.0% change in trailing-twelve-month accounts receivables.

Context

  • Accounts receivables amounted to 4.9% of revenue in FY2025, down 4.9 pp from a year earlier.
  • Accounts receivables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +32.0% toward the trailing-twelve-month pace of +307.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$9.6M-398.2% QoQ
Last fiscal yearDec 2025
$12.22M+148.9% YoY
LTMMar 2026
$9.9M+307.0% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.0%——
1 year+148.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
12.22M USD
Year-over-year change
+148.9%

Accounts Receivables vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's LTM Mar 2026 accounts receivables of $9.9M is the largest of the 9 companies compared; the peer median is $0.
  • Its year-over-year change of +307.0% is the highest of 5, against a peer median of -63.3%.
  • Accounts receivables amounts to 4.2% of revenue for AMWL, versus a peer median of 8.1%.
AMWL Competitors Peer median
Accounts Receivables for AMWL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$9.9M +307.0%—4.2%
DTILPrecision BioSciences, Inc.LTM Mar 2026$5.47M -147.5%—12.1%
ATYRaTyr Pharma, Inc.LTM Mar 2026$511K -26.6%—268.9%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$506.64K +121.4%-1.5%4.2%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$0 ——0.0%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$0 ———
IMUXImmunic, Inc.LTM Mar 2026$0 ———
BMEABiomea Fusion, Inc.LTM Mar 2026$0 ———
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 -100.0%——
Peer median (excluding AMWL) $0-63.3%-1.5%8.1%

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(176.78M)(272.07M)(675.16M)(208.14M)(95.7M)
Depreciation & Amortization16.09M26.17M31.92M33.43M33.96M
Deferred Income Tax(6.25M)(2.52M)(242K)(243K)(1.11M)
Stock-Based Compensation43.81M67.68M72.25M47.54M22.01M
Change in Working Capital(27.72M)(28.1M)(15.51M)(9.98M)(26.8M)
Accounts Receivables(512K)(8.14M)3.25M(25.01M)12.22M
Inventory1.6M(1.21M)2.09M1.9M1.17M
Accounts Payables5.55M(4.78M)(2.36M)159K(3.42M)
Other Working Capital(34.35M)(13.97M)(18.48M)12.97M(36.77M)
Other Non-Cash Items9.31M16.53M438.4M57.6M1.68M
Operating Cash Flow(141.54M)(192.32M)(148.34M)(127.34M)(65.95M)
Capital Expenditures(559K)(10.45M)(15.25M)(15.22M)(21K)
Acquisitions (Net)(159.07M)(1.96M)0(3.43M)18.32M
Purchases of Investments2.55M(499.22M)(389.99M)0(1M)
Sales of Investments100M500M389.99M00
Other Investing Activities(2.55M)0(18.88M)(15.1M)(196K)
Investing Cash Flow(59.63M)(11.63M)(19.17M)(18.65M)17.1M
Debt Repayment00000
Common Stock Issued0000844K
Common Stock Repurchased(15.04M)(360K)(586K)(3K)(4K)
Dividends Paid00000
Other Financing Activities20.79M(3.25M)2.73M1.38M0
Financing Cash Flow5.75M(3.61M)2.15M1.38M840K
Effect of Forex Changes(84K)(305K)(1.14M)887K2.02M
Net Change in Cash(195.5M)(207.87M)(166.51M)(143.72M)(45.99M)
Free Cash Flow(142.1M)(202.77M)(163.59M)(142.56M)(65.97M)

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.